The monophasic Salmonella Typhimurium outbreak was identified at the end of January 2024. Initially, it appeared to be confined to preschool children in Húsavík, but cases were then detected in ...
SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technology and currently in Phase I for Liver Cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback